LSV Asset Management Has $117.81 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

LSV Asset Management cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,511,857 shares of the pharmacy operator’s stock after selling 207,726 shares during the period. LSV Asset Management owned 0.52% of Walgreens Boots Alliance worth $117,805,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after acquiring an additional 10,962,030 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Walgreens Boots Alliance by 21.5% during the 3rd quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after acquiring an additional 3,013,807 shares during the last quarter. Morgan Stanley raised its stake in shares of Walgreens Boots Alliance by 15.8% in the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after acquiring an additional 1,720,228 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in Walgreens Boots Alliance by 1,985.1% in the 4th quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock worth $23,226,000 after purchasing an additional 846,884 shares during the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC boosted its position in Walgreens Boots Alliance by 85.1% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 1,752,170 shares of the pharmacy operator’s stock worth $38,968,000 after purchasing an additional 805,332 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Up 1.6 %

WBA stock traded up $0.28 during trading on Friday, hitting $17.81. The company had a trading volume of 7,528,623 shares, compared to its average volume of 10,049,602. The stock has a market cap of $15.36 billion, a price-to-earnings ratio of -2.54, a PEG ratio of 1.09 and a beta of 0.80. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $19.59 and a 200-day moving average price of $21.59. Walgreens Boots Alliance, Inc. has a 12 month low of $17.25 and a 12 month high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.16 earnings per share. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.61%. Walgreens Boots Alliance’s dividend payout ratio is -14.29%.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on WBA shares. Truist Financial reaffirmed a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Bank of America cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, April 3rd. Finally, HSBC reaffirmed a “reduce” rating and set a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.